15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $150M | -$74620 | 100.0% | -48.7% | -$83M | — | $57M |
| 2024 | $150M | -$66966 | 99.4% | -73.7% | -$72M | — | $183M |
| 2023 | $59M | -$9058 | 98.9% | -286.4% | -$80M | — | $101M |
| 2022 | $152M | -$120M | 97.8% | -79.9% | -$91M | — | $109M |
| 2021 | $77M | -$202M | 96.6% | -261.9% | -$150M | — | $123M |
| 2020 | $105M | -$130M | 100.0% | -125.0% | -$118M | — | $181M |
| 2019 | $64M | -$152M | 100.0% | -276.0% | -$139M | — | $126M |
| 2018 | $60M | -$171M | 0.0% | -284.8% | -$178M | — | $220M |
| 2017 | $158M | -$20M | 0.0% | -14.0% | -$15M | — | $212M |
| 2016 | $92M | -$59M | 0.0% | -65.3% | — | — | $84M |
| 2015 | $101M | -$20M | 0.0% | -20.0% | — | — | $196M |
| 2014 | $48M | -$38M | 0.0% | -80.2% | — | — | $158M |
| 2013 | $58M | -$261000 | 0.0% | 0.6% | -$17M | — | $116M |
| 2012 | $64M | $8M | 0.0% | 12.9% | -$8M | — | $48M |
| 2011 | $57M | $7M | 0.0% | 9.2% | $6M | — | $55M |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $21M | -$37M | 0.0% | -161.0% | -$36M | — | $67M |
| Dec '25 | $41M | -$14M | 100.0% | -29.3% | $43M | — | $57M |
| Sep '25 | $73M | $17M | 100.0% | 25.6% | -$31M | — | $80M |
| Jun '25 | $22M | -$36M | 100.0% | -165.3% | -$48M | — | $131M |
| Mar '25 | $13M | -$41M | 100.0% | -323.1% | -$47M | — | $146M |
| Dec '24 | $19M | -$15M | 98.8% | -273.0% | -$39M | — | $183M |
| Sep '24 | $111M | $56M | 99.8% | 48.9% | $60M | — | $180M |
| Jun '24 | $11M | -$56M | 98.4% | -538.9% | -$46M | — | $84M |
| Mar '24 | $9M | -$52M | 97.0% | -590.4% | -$47M | — | $80M |
| Dec '23 | $11M | -$46M | 98.5% | -460.4% | -$29M | — | $101M |
| Sep '23 | $10M | $18M | 99.2% | -341.5% | -$36M | — | $90M |
| Jun '23 | $13M | $57M | 98.0% | -342.3% | -$2M | — | $109M |
| Mar '23 | $24M | -$38M | 99.5% | -156.9% | -$13M | — | $224M |
| Dec '22 | $73M | $13M | 99.8% | 16.4% | $29M | — | $109M |
| Sep '22 | $42M | -$25M | 92.8% | -59.8% | -$10M | — | $84M |
| Jun '22 | $26M | -$41M | 99.3% | -160.8% | -$50M | — | $21M |
| Mar '22 | $11M | -$66M | 99.6% | -600.3% | -$59M | — | $47M |
| Dec '21 | $14M | -$58M | 93.3% | -411.6% | -$56M | — | $123M |
| Sep '21 | $16M | -$53M | 89.4% | -338.3% | -$17M | — | $191M |
| Jun '21 | $31M | -$40M | 99.9% | -131.0% | -$48M | — | $189M |
How the market has priced MGNX against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, MACROGENICS INC's revenue has grown 7.3% per year. These are computed facts, not advice.
As of FY2025, MACROGENICS INC reported — of total debt against $57M of cash; operating income covered interest expense -8.6×.
In FY2025, gross margin was 100.0%, operating margin -48.7%, and net margin -0.0%.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.